{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:17:36Z","timestamp":1776763056281,"version":"3.51.2"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"DOI":"10.1007\/s44197-025-00360-7","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T16:39:16Z","timestamp":1738773556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multidrug Resistance Tuberculosis in the Context of Co-Infection in Ethiopia: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"15","author":[{"given":"Bezawit Kassaw","family":"Hailu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitayew","family":"Demessie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abebe Tesfaye","family":"Gessese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8773-2698","authenticated-orcid":false,"given":"Gashaw Getaneh","family":"Dagnaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-9334","authenticated-orcid":false,"given":"Haileyesus","family":"Dejene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"360_CR1","unstructured":"WHO. World Health Organization (WHO). Global tuberculosis report. Geneva, Switzerland: 2017."},{"key":"360_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1021\/acsinfecdis.8b00241","volume":"5","author":"BL Fitzgerald","year":"2019","unstructured":"Fitzgerald BL, Islam MN, Graham B, Mahapatra S, Webb K, Boom WH, et al. Elucidation of a human urine metabolite as a seryl-leucine glycopeptide and as a biomarker of effective anti-tuberculosis therapy. ACS Infect Dis. 2019;5:353\u201364. https:\/\/doi.org\/10.1021\/acsinfecdis.8b00241.","journal-title":"ACS Infect Dis"},{"key":"360_CR3","doi-asserted-by":"publisher","DOI":"10.22541\/au.172537510.01163065\/v1","author":"L Xu","year":"2024","unstructured":"Xu L, Li H, Li S, Pan H, Li S, Yang Y, et al. Predicting Risk areas of cattle, Sheep and Goat tuberculosis in China based on Air pollutants and Meteorological Factors-predicting-risk-areas-of-cattle-sheep-and-goat-tuberculosis-in-china-based-on-air-pollutants-and-meteorological-factors. Authorea Prepr 2024. https:\/\/doi.org\/10.22541\/au.172537510.01163065\/v1.","journal-title":"Authorea Prepr"},{"key":"360_CR4","unstructured":"NIAID. National Institute of Allergy and Infectious Diseases (NIAID). Tuberculosis. 2024."},{"key":"360_CR5","unstructured":"CDC. Centers for Disease Control and Prevention (CDC). Tuberculosis (TB). 2024."},{"key":"360_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cid\/ciw778","volume":"64","author":"DM Lewinsohn","year":"2017","unstructured":"Lewinsohn DM, Leonard MK, Lobue PA, Cohn DL, Daley CL, Desmond E, et al. Official American thoracic society\/Infectious diseases society of America\/Centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:111\u20135. https:\/\/doi.org\/10.1093\/cid\/ciw778.","journal-title":"Clin Infect Dis"},{"key":"360_CR7","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1056\/NEJMra1413919","volume":"373","author":"CR Horsburgh","year":"2015","unstructured":"Horsburgh CR, Barry CE, Lange C. Treatment of tuberculosis. N Engl J Med. 2015;373:2149\u201360. https:\/\/doi.org\/10.1056\/NEJMra1413919.","journal-title":"N Engl J Med"},{"key":"360_CR8","doi-asserted-by":"publisher","first-page":"1127916","DOI":"10.3389\/fcimb.2023.1127916","volume":"13","author":"C Wu","year":"2023","unstructured":"Wu C, Yi H, Hu Y, Luo D, Tang Z, Wen X, et al. Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis. Front Cell Infect Microbiol. 2023;13:1127916. https:\/\/doi.org\/10.3389\/fcimb.2023.1127916.","journal-title":"Front Cell Infect Microbiol"},{"key":"360_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.14300","volume":"1467","author":"J Osei Sekyere","year":"2020","unstructured":"Osei Sekyere J, Maningi NE, Fourie PB. Mycobacterium tuberculosis, antimicrobials, immunity, and lung\u2013gut microbiota crosstalk: current updates and emerging advances. Ann N Y Acad Sci. 2020;1467:21\u201347. https:\/\/doi.org\/10.1111\/nyas.14300.","journal-title":"Ann N Y Acad Sci"},{"key":"360_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.21775\/cimb.008.097","volume":"8","author":"R Johnson","year":"2006","unstructured":"Johnson R, Streicher EM, Louw GE, Warren RM, Van Helden PD, Victor TC. Drug Resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol. 2006;8:97\u2013112. https:\/\/doi.org\/10.21775\/cimb.008.097.","journal-title":"Curr Issues Mol Biol"},{"key":"360_CR11","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.2147\/IDR.S363628","volume":"15","author":"A Badgeba","year":"2022","unstructured":"Badgeba A, Shimbre MS, Gebremichael MA, Bogale B, Berhanu M, Abdulkadir H. Determinants of Multidrug-resistant Mycobacterium tuberculosis infection: a Multicenter Study from Southern Ethiopia. Infect Drug Resist. 2022;15:3523\u201335. https:\/\/doi.org\/10.2147\/IDR.S363628.","journal-title":"Infect Drug Resist"},{"key":"360_CR12","doi-asserted-by":"publisher","unstructured":"Millard J, Ugarte-Gil C, Moore DAJ. Multidrug resistant tuberculosis. BMJ. 2015;350. https:\/\/doi.org\/10.1136\/bmj.h882.","DOI":"10.1136\/bmj.h882"},{"key":"360_CR13","doi-asserted-by":"publisher","unstructured":"Girum T, Muktar E, Lentiro K, Wondiye H, Shewangizaw M. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines. 2018;4. https:\/\/doi.org\/10.1186\/s40794-018-0065-5.","DOI":"10.1186\/s40794-018-0065-5"},{"key":"360_CR14","unstructured":"WHO. World Health Organization (WHO). Global TB report 2022. Geneva, Switzerland: 2022."},{"key":"360_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40794-024-00224-1","volume":"10","author":"G Gebremariam","year":"2024","unstructured":"Gebremariam G, Kiros M, Hagos S, Hadush H, Gebremichael A, Gebrekirstos G, et al. Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018\u20132023: a six-year retrospective study. Trop Dis Travel Med Vaccines. 2024;10:15. https:\/\/doi.org\/10.1186\/s40794-024-00224-1.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"360_CR16","doi-asserted-by":"publisher","first-page":"33863","DOI":"10.1016\/j.heliyon.2024.e33863","volume":"10","author":"TA Dejene","year":"2024","unstructured":"Dejene TA, Hailu GG, Kahsay AG, Wasihun AG. Mycobacterium tuberculosis and rifampicin-resistant tuberculosis among tuberculosis presumptive patients in selected zones of Tigray, Northern Ethiopia, 2016\u20132019. Heliyon. 2024;10:33863. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33863.","journal-title":"Heliyon"},{"key":"360_CR17","doi-asserted-by":"publisher","unstructured":"Salari N, Kanjoori AH, Hosseinian-Far A, Hasheminezhad R, Mansouri K, Mohammadi M. Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis. Infect Dis Poverty. 2023;12. https:\/\/doi.org\/10.1186\/s40249-023-01107-x.","DOI":"10.1186\/s40249-023-01107-x"},{"key":"360_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20544-y","volume":"12","author":"D Mistry","year":"2021","unstructured":"Mistry D, Litvinova M, Pastore y Piontti A, Chinazzi M, Fumanelli L, Gomes MFC, et al. Inferring high-resolution human mixing patterns for disease modeling. Nat Commun. 2021;12:1\u201312. https:\/\/doi.org\/10.1038\/s41467-020-20544-y.","journal-title":"Nat Commun"},{"key":"360_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-023-08501-8","volume":"23","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Li T, Lin S, Chen D, Du Y, Chen J, et al. Characteristics and treatment outcomes of co-infected tuberculosis patients with human immunodeficiency virus in Southeast China, 2012\u20132021. BMC Infect Dis. 2023;23:1\u20137. https:\/\/doi.org\/10.1186\/s12879-023-08501-8.","journal-title":"BMC Infect Dis"},{"key":"360_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-024-01230-3","volume":"13","author":"SX Zhang","year":"2024","unstructured":"Zhang SX, Wang JC, Yang J, Lv S, Duan L, Lu Y, et al. Epidemiological features and temporal trends of the co-infection between HIV and Tuberculosis, 1990\u20132021: findings from the global burden of Disease Study 2021. Infect Dis Poverty. 2024;13:1\u201316. https:\/\/doi.org\/10.1186\/s40249-024-01230-3.","journal-title":"Infect Dis Poverty"},{"key":"360_CR21","doi-asserted-by":"publisher","unstructured":"Gopalaswamy R, Shanmugam S, Mondal R, Subbian S. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020;27. https:\/\/doi.org\/10.1186\/s12929-020-00667-6.","DOI":"10.1186\/s12929-020-00667-6"},{"key":"360_CR22","doi-asserted-by":"publisher","unstructured":"Wakjira MK, Sandy PT, Mavhandu-Mudzusi AH. Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia. PLoS ONE. 2022;17. https:\/\/doi.org\/10.1371\/journal.pone.0262318.","DOI":"10.1371\/journal.pone.0262318"},{"key":"360_CR23","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.2147\/IDR.S412951","volume":"16","author":"A Seid","year":"2023","unstructured":"Seid A, Girma Y, Abebe A, Dereb E, Kassa M, Berhane N. Characteristics of TB\/HIV co-infection and patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia. Infect Drug Resist. 2023;16:3829\u201345. https:\/\/doi.org\/10.2147\/IDR.S412951.","journal-title":"Infect Drug Resist"},{"key":"360_CR24","doi-asserted-by":"publisher","unstructured":"Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, et al. Drug-resistance patterns of mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS ONE. 2018;13. https:\/\/doi.org\/10.1371\/journal.pone.0197737.","DOI":"10.1371\/journal.pone.0197737"},{"key":"360_CR25","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.2147\/IDR.S326798","volume":"14","author":"Z Amin","year":"2021","unstructured":"Amin Z, Mitiku H, Marami D, Shume T, Weldegebreal F. Magnitude of multidrug resistance and associated factors of pulmonary tuberculosis among adult smear positive patients in eastern Ethiopia. Infect Drug Resist. 2021;14:4493\u2013500. https:\/\/doi.org\/10.2147\/IDR.S326798.","journal-title":"Infect Drug Resist"},{"key":"360_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijid.2015.08.013","volume":"39","author":"G Mulisa","year":"2015","unstructured":"Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39:57\u201361. https:\/\/doi.org\/10.1016\/j.ijid.2015.08.013.","journal-title":"Int J Infect Dis"},{"key":"360_CR27","doi-asserted-by":"publisher","unstructured":"Seid A, Kassa M, Girma Y, Dereb E, Nureddin S, Abebe A, et al. Molecular characterization of genetic mutations with fitness loss in pulmonary tuberculosis patients associated with HIV co-infection in Northwest Amhara, Ethiopia. SAGE Open Med. 2023;11. https:\/\/doi.org\/10.1177\/20503121231208266.","DOI":"10.1177\/20503121231208266"},{"key":"360_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1202-7","volume":"15","author":"F Mekonnen","year":"2015","unstructured":"Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis. 2015;15:1\u20136. https:\/\/doi.org\/10.1186\/s12879-015-1202-7.","journal-title":"BMC Infect Dis"},{"key":"360_CR29","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"360_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.catena.2012.12.007","volume":"104","author":"B Berhanu","year":"2013","unstructured":"Berhanu B, Melesse AM, Seleshi Y. GIS-based hydrological zones and soil geo-database of Ethiopia. CATENA. 2013;104:21\u201331. https:\/\/doi.org\/10.1016\/j.catena.2012.12.007.","journal-title":"CATENA"},{"key":"360_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-8290-z","volume":"20","author":"D Datiko","year":"2020","unstructured":"Datiko D, Hadgu A, Jerene D, Suarez PG. High urban tuberculosis case notification rates can be misleading: evidence from an urban setting in Ethiopia. BMC Public Health. 2020;20:1\u20136. https:\/\/doi.org\/10.1186\/s12889-020-8290-z.","journal-title":"BMC Public Health"},{"key":"360_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/2046-4053-4-1","volume":"20","author":"D Moher","year":"2016","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Rev Esp Nutr Humana Y Diet. 2016;20:148\u201360. https:\/\/doi.org\/10.1186\/2046-4053-4-1.","journal-title":"Rev Esp Nutr Humana Y Diet"},{"key":"360_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"360_CR34","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186.","journal-title":"Stat Med"},{"key":"360_CR35","doi-asserted-by":"publisher","unstructured":"Chen B, Benedetti A. Quantifying heterogeneity in individual participant data meta-analysis with binary outcomes. Syst Rev. 2017;6. https:\/\/doi.org\/10.1186\/s13643-017-0630-4.","DOI":"10.1186\/s13643-017-0630-4"},{"key":"360_CR36","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974\u20138. https:\/\/doi.org\/10.1136\/jech-2013-203104.","journal-title":"J Epidemiol Community Health"},{"key":"360_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-32831-2","volume":"8","author":"B Scharnb\u00f6ck","year":"2018","unstructured":"Scharnb\u00f6ck B, Roch FF, Richter V, Funke C, Firth CL, Obritzhauser W, et al. A meta-analysis of bovine viral Diarrhoea virus (BVDV) prevalences in the global cattle population. Sci Rep. 2018;8:1\u201315. https:\/\/doi.org\/10.1038\/s41598-018-32831-2.","journal-title":"Sci Rep"},{"key":"360_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature25753","volume":"555","author":"J Gurevitch","year":"2018","unstructured":"Gurevitch J, Koricheva J, Nakagawa S, Stewart G. Meta-analysis and the science of research synthesis. Nature. 2018;555:175\u201382. https:\/\/doi.org\/10.1038\/nature25753.","journal-title":"Nature"},{"key":"360_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105\u201314. https:\/\/doi.org\/10.1016\/j.cct.2006.04.004.","journal-title":"Contemp Clin Trials"},{"key":"360_CR40","doi-asserted-by":"publisher","unstructured":"Borenstein M. Software for publication bias. Publ Bias Meta-Analysis Prev Assess Adjust. 2006;193\u2013220. https:\/\/doi.org\/10.1002\/0470870168.ch11.","DOI":"10.1002\/0470870168.ch11"},{"key":"360_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.k4597","volume":"364","author":"RD Riley","year":"2019","unstructured":"Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, et al. A guide to systematic review and meta-analysis of prognostic factor studies. BMJ. 2019;364:1\u201313. https:\/\/doi.org\/10.1136\/bmj.k4597.","journal-title":"BMJ"},{"key":"360_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/idr.s127903","volume":"10","author":"M Brhane","year":"2017","unstructured":"Brhane M, Kebede A, Petros Y. Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia. Infect Drug Resist. 2017;10:75\u201383. https:\/\/doi.org\/10.2147\/idr.s127903.","journal-title":"Infect Drug Resist"},{"key":"360_CR43","doi-asserted-by":"publisher","unstructured":"Gobena D, Ameya G, Haile K, Abreha G, Worku Y, Debela T. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Ann Clin Microbiol Antimicrob. 2018;17. https:\/\/doi.org\/10.1186\/s12941-018-0283-8.","DOI":"10.1186\/s12941-018-0283-8"},{"key":"360_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/tmi.12826","volume":"22","author":"KA Alene","year":"2017","unstructured":"Alene KA, Viney K, McBryde ES, Tsegaye AT, Clements ACA. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia. Trop Med Int Heal. 2017;22:351\u201362. https:\/\/doi.org\/10.1111\/tmi.12826.","journal-title":"Trop Med Int Heal"},{"key":"360_CR45","doi-asserted-by":"publisher","first-page":"e0236362","DOI":"10.1371\/journal.pone.0236362","volume":"15","author":"LN Welekidan","year":"2020","unstructured":"Welekidan LN, Skjerve E, Dejene TA, Gebremichael MW, Brynildsrud O, Agdestein A, et al. Characteristics of pulmonary multidrugresistant tuberculosis patients in Tigray Region, Ethiopia: a cross-sectional study. PLoS ONE. 2020;15:e0236362. https:\/\/doi.org\/10.1371\/journal.pone.0236362.","journal-title":"PLoS ONE"},{"key":"360_CR46","doi-asserted-by":"publisher","unstructured":"Bade AB, Mega TA. Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study. PLoS ONE. 2020;15. https:\/\/doi.org\/10.1371\/journal.pone.0241684.","DOI":"10.1371\/journal.pone.0241684"},{"key":"360_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4314\/ejhs.v31i1.4","volume":"31","author":"GY Ambaye","year":"2021","unstructured":"Ambaye GY, Tsegaye GW. Factors Associated with Multi-drug resistant tuberculosis among TB patients in selected treatment centers of Amhara Region: a case-control study. Ethiop J Health Sci. 2021;31:25\u201334. https:\/\/doi.org\/10.4314\/ejhs.v31i1.4.","journal-title":"Ethiop J Health Sci"},{"key":"360_CR48","doi-asserted-by":"publisher","unstructured":"Kassa GM, Woldetsadik AT, Gelaw YA, Alemayehu TT, Tsegaye AT, Tamirat KS, et al. Predictors of mortality among multidrug-resistant tuberculosis patients in central Ethiopia; a retrospective follow-up study. Epidemiol Infect. 2020;148. https:\/\/doi.org\/10.1017\/S0950268820002514.","DOI":"10.1017\/S0950268820002514"},{"key":"360_CR49","doi-asserted-by":"publisher","unstructured":"Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6. https:\/\/doi.org\/10.1136\/bmjopen-2016-011458.","DOI":"10.1136\/bmjopen-2016-011458"},{"key":"360_CR50","unstructured":"WHO. World Health Organization (WHO). Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27\u201329 October 2020. Geneva, Switzerland: 2021."},{"key":"360_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2323-y","volume":"17","author":"S Eshetie","year":"2017","unstructured":"Eshetie S, Gizachew M, Dagnew M, Kumera G, Woldie H, Ambaw F, et al. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC Infect Dis. 2017;17:1\u201312. https:\/\/doi.org\/10.1186\/s12879-017-2323-y.","journal-title":"BMC Infect Dis"},{"key":"360_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7104921","volume":"2018","author":"SW Asgedom","year":"2018","unstructured":"Asgedom SW, Teweldemedhin M, Gebreyesus H. Prevalence of Multidrug-resistant tuberculosis and Associated Factors in Ethiopia: a systematic review. J Pathog. 2018;2018:1\u20138. https:\/\/doi.org\/10.1155\/2018\/7104921.","journal-title":"J Pathog"},{"key":"360_CR53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/tropicalmed7100300","volume":"7","author":"MA Reta","year":"2022","unstructured":"Reta MA, Tamene BA, Abate BB, Mensah E, Maningi NE, Fourie PB. Mycobacterium tuberculosis Drug Resistance in Ethiopia: an updated systematic review and Meta-analysis. Trop Med Infect Dis. 2022;7:300. https:\/\/doi.org\/10.3390\/tropicalmed7100300.","journal-title":"Trop Med Infect Dis"},{"key":"360_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijid.2023.04.392","volume":"132","author":"G Diriba","year":"2023","unstructured":"Diriba G, Alemu A, Yenew B, Tola HH, Gamtesa DF, Mollalign H, et al. Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2023;132:50\u201363. https:\/\/doi.org\/10.1016\/j.ijid.2023.04.392.","journal-title":"Int J Infect Dis"},{"key":"360_CR55","doi-asserted-by":"publisher","first-page":"e82235","DOI":"10.1371\/journal.pone.0082235","volume":"9","author":"YM Mesfin","year":"2014","unstructured":"Mesfin YM, Hailemariam D, Biadglign S, Kibret KT. Association between HIV\/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS ONE. 2014;9:e82235. https:\/\/doi.org\/10.1371\/journal.pone.0082235.","journal-title":"PLoS ONE"},{"key":"360_CR56","doi-asserted-by":"publisher","unstructured":"Eshetie S, Moges F, Dagnew M. Multidrug-resistant tuberculosis in Ethiopian settings and its association with previous antituberculosis treatment: A systematic review and meta-analysis. Int. J. Mycobacteriology, vol. 5, Elsevier Ltd; 2016, pp. S119\u201320. https:\/\/doi.org\/10.1016\/j.ijmyco.2016.09.022","DOI":"10.1016\/j.ijmyco.2016.09.022"},{"key":"360_CR57","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/1471-0528.16573","volume":"128","author":"KA Alene","year":"2021","unstructured":"Alene KA, Jegnie A, Adane AA. Multidrug-resistant tuberculosis during pregnancy and adverse birth outcomes: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol. 2021;128:1125\u201333. https:\/\/doi.org\/10.1111\/1471-0528.16573.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"360_CR58","doi-asserted-by":"publisher","first-page":"e0270272","DOI":"10.1371\/journal.pone.0270272","volume":"17","author":"KA Molla","year":"2022","unstructured":"Molla KA, Reta MA, Ayene YY. Prevalence of multidrug-resistant tuberculosis in East Africa: a systematic review and meta-analysis. PLoS ONE. 2022;17:e0270272. https:\/\/doi.org\/10.1371\/journal.pone.0270272.","journal-title":"PLoS ONE"},{"key":"360_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3604-9","volume":"18","author":"M Teweldemedhin","year":"2018","unstructured":"Teweldemedhin M, Asres N, Gebreyesus H, Asgedom SW. Tuberculosis-human immunodeficiency virus (HIV) co-infection in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2018;18:1\u20139. https:\/\/doi.org\/10.1186\/s12879-018-3604-9.","journal-title":"BMC Infect Dis"},{"key":"360_CR60","doi-asserted-by":"publisher","unstructured":"Xi Y, Zhang W, Qiao RJ, Tang J. Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis. PLoS ONE. 2022;17. https:\/\/doi.org\/10.1371\/journal.pone.0270003.","DOI":"10.1371\/journal.pone.0270003"},{"key":"360_CR61","doi-asserted-by":"publisher","first-page":"5","DOI":"10.11604\/pamj.supp.2016.25.2.9203","volume":"25","author":"M Dessalegn","year":"2016","unstructured":"Dessalegn M, Daniel E, Behailu S, Wagnew M, Nyagero J. Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia. Pan Afr Med J. 2016;25:5. https:\/\/doi.org\/10.11604\/pamj.supp.2016.25.2.9203.","journal-title":"Pan Afr Med J"},{"key":"360_CR62","doi-asserted-by":"publisher","unstructured":"Mersha MM, Negash BT, Ali MM. Prevalence and Associated factors of Multidrug-resistant tuberculosis among tuberculosis patients at Yirgalem General Hospital, Sidama Regional State, Ethiopia: a cross-sectional study based on five years of secondary data. Ethiop J Heal Dev. 2024;38. https:\/\/doi.org\/10.20372\/ejhd.v38i2.6175.","DOI":"10.20372\/ejhd.v38i2.6175"},{"key":"360_CR63","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4314\/ahs.v15i2.9","volume":"15","author":"W Mulu","year":"2015","unstructured":"Mulu W, Mekonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in amhara national regional state. Afr Health Sci. 2015;15:368\u201377. https:\/\/doi.org\/10.4314\/ahs.v15i2.9.","journal-title":"Afr Health Sci"},{"key":"360_CR64","doi-asserted-by":"publisher","first-page":"e0147621","DOI":"10.1371\/journal.pone.0147621","volume":"11","author":"MH Workneh","year":"2016","unstructured":"Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in south-eastern Amhara region, Ethiopia: a cross sectional study. PLoS ONE. 2016;11:e0147621. https:\/\/doi.org\/10.1371\/journal.pone.0147621.","journal-title":"PLoS ONE"},{"key":"360_CR65","doi-asserted-by":"publisher","unstructured":"Tegegne BS, Mengesha MM, Teferra AA, Awoke MA, Habtewold TD. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Syst Rev. 2018;7. https:\/\/doi.org\/10.1186\/s13643-018-0828-0.","DOI":"10.1186\/s13643-018-0828-0"},{"key":"360_CR66","doi-asserted-by":"publisher","unstructured":"Adane HT, Howe RC, Wassie L, Magee MJ. Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: a prospective health facility-based study. J Clin Tuberc Other Mycobact Dis. 2023;31. https:\/\/doi.org\/10.1016\/j.jctube.2023.100368.","DOI":"10.1016\/j.jctube.2023.100368"},{"key":"360_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05749-2","volume":"21","author":"ZZ Sultana","year":"2021","unstructured":"Sultana ZZ, Hoque FU, Beyene J, Akhlak-Ul-Islam M, Khan MHR, Ahmed S, et al. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2021;21:1\u201313. https:\/\/doi.org\/10.1186\/s12879-020-05749-2.","journal-title":"BMC Infect Dis"},{"key":"360_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1513\/AnnalsATS.201902-185CME","volume":"17","author":"JW Wilson","year":"2020","unstructured":"Wilson JW, Nilsen DM, Marks SM. Multidrug-resistant tuberculosis in patients with human immunodeficiency virus management considerations within high-resourced settings. Ann Am Thorac Soc. 2020;17:16\u201323. https:\/\/doi.org\/10.1513\/AnnalsATS.201902-185CME.","journal-title":"Ann Am Thorac Soc"},{"key":"360_CR69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3947\/ic.2021.0085","volume":"53","author":"CM Lee","year":"2021","unstructured":"Lee CM, Lee E, Bang JH, Park SW, Park WB, Oh MD, et al. Prevalence of Multidrug-resistant tuberculosis in HIV\/Tuberculosis co-infected patients. Infect Chemother. 2021;53:792\u20135. https:\/\/doi.org\/10.3947\/ic.2021.0085.","journal-title":"Infect Chemother"},{"key":"360_CR70","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41598-017-01213-5","volume":"7","author":"Q Liu","year":"2017","unstructured":"Liu Q, Li W, Xue M, Chen Y, Du X, Wang C, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci Rep. 2017;7:1090. https:\/\/doi.org\/10.1038\/s41598-017-01213-5.","journal-title":"Sci Rep"},{"key":"360_CR71","doi-asserted-by":"publisher","first-page":"1244450","DOI":"10.3389\/fpubh.2023.1244450","volume":"11","author":"Aur Rehman","year":"2023","unstructured":"Rehman Aur, Khattak M, Mushtaq U, Latif M, Ahmad I, Rasool MF, et al. The impact of diabetes mellitus on the emergence of multi-drug resistant tuberculosis and treatment failure in TB-diabetes comorbid patients: a systematic review and meta-analysis. Front Public Heal. 2023;11:1244450. https:\/\/doi.org\/10.3389\/fpubh.2023.1244450.","journal-title":"Front Public Heal"},{"key":"360_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3826980","volume":"2017","author":"MG Beza","year":"2017","unstructured":"Beza MG, Hunegnaw E, Tiruneh M. Prevalence and Associated factors of tuberculosis in prisons settings of East Gojjam Zone, Northwest Ethiopia. Int J Bacteriol. 2017;2017:1\u20137. https:\/\/doi.org\/10.1155\/2017\/3826980.","journal-title":"Int J Bacteriol"},{"key":"360_CR73","doi-asserted-by":"publisher","unstructured":"Mohammed H, Oljira L, Roba KT, Ngadaya E, Ajeme T, Haile T, et al. Burden of tuberculosis and challenges related to screening and diagnosis in Ethiopia. J Clin Tuberc Other Mycobact Dis. 2020;19. https:\/\/doi.org\/10.1016\/j.jctube.2020.100158.","DOI":"10.1016\/j.jctube.2020.100158"},{"key":"360_CR74","doi-asserted-by":"publisher","unstructured":"Mehari K, Asmelash T, Hailekiros H, Wubayehu T, Godefay H, Araya T, et al. Prevalence and Factors Associated with Multidrug-resistant tuberculosis (MDR-TB) among presumptive MDR-TB patients in Tigray Region, Northern Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019. https:\/\/doi.org\/10.1155\/2019\/2923549.","DOI":"10.1155\/2019\/2923549"},{"key":"360_CR75","doi-asserted-by":"publisher","unstructured":"Lakew Y, Benedict S, Haile D. Social determinants of HIV infection, hotspot areas and subpopulation groups in Ethiopia: evidence from the National Demographic and Health Survey in 2011. BMJ Open. 2015;5. https:\/\/doi.org\/10.1136\/BMJOPEN-2015-008669.","DOI":"10.1136\/BMJOPEN-2015-008669"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-025-00360-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-025-00360-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-025-00360-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T16:39:24Z","timestamp":1738773564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-025-00360-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1007\/s44197-025-00360-7","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not applicable. No animal or human experimentation was undertaken.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"19"}}